Clinical Trials Directory

Trials / Conditions / Parkinson's Disease

Parkinson's Disease

1,250 registered clinical trials studyying Parkinson's Disease104 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingTerazosin And Metabolic Engagement in Parkinson's Disease
NCT07288450
Nandakumar NarayananPhase 1 / Phase 2
Not Yet RecruitingMild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain
NCT07214974
Noah Tech, Corp.EARLY_Phase 1
Not Yet RecruitingA Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
NCT07514858
H. Lundbeck A/SPhase 2
RecruitingPhase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Diseas
NCT07371338
Innopeutics CorporationPhase 1
Not Yet RecruitingNeural Mechanisms of Aerobic Exercise Benefits in PD With DBS
NCT07442747
The Cleveland ClinicN/A
Not Yet RecruitingAuditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive
NCT07441915
University of ZurichN/A
Enrolling By InvitationRadiation Therapy (RT) for Parkinson's Disease (PD)
NCT07218952
Mayo ClinicN/A
Not Yet RecruitingAt-home taVNS for Neurorehabilitation in Parkinson's Disease
NCT07536022
Medical University of South CarolinaN/A
RecruitingA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptom
NCT07330258
Bayer
RecruitingEffects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease
NCT07384429
YangPanPhase 4
RecruitingEffects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in P
NCT07384442
YangPanN/A
RecruitingA Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcu
NCT07382440
AbbVie
RecruitingKetamine for Veterans With Parkinson's Disease
NCT06231563
VA Office of Research and DevelopmentPhase 2
Not Yet RecruitingReal-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier
NCT07227896
AbbVie
RecruitingNon-invasive VNS for PD Gait
NCT06562569
VA Office of Research and DevelopmentN/A
Not Yet RecruitingComparing Biomarker-Guided DBS Programming With Standard Clinical Monopolar Programming
NCT07369310
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauN/A
RecruitingEtiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
NCT07386015
Tianjin Huanhu Hospital
RecruitingUltra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NCT07509125
Universitaire Ziekenhuizen KU LeuvenN/A
RecruitingRhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease
NCT07378722
Rumesa ButtN/A
Not Yet RecruitingOptimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease
NCT06857851
VA Office of Research and Development
RecruitingSpeech Learning and Speech Production in Parkinson's Disease
NCT07403539
State University of New York at BuffaloN/A
RecruitingVirtual Reality Verses Conventional Physical Therapy in Parkinson's Disease Patients
NCT07359716
Montiha AzeemN/A
Not Yet RecruitingAnterior Foot Wedge With Neuromuscular Training for Balance in Parkinson's Disease
NCT07334847
MTI UniversityN/A
RecruitingD-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
NCT07312110
Haukeland University HospitalPhase 2
Not Yet RecruitingStudy on the Efficacy of Temporal Interference Stimulation (TIS) for Parkinson's Disease
NCT07312279
Zhongnan HospitalN/A
RecruitingFeasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Diseas
NCT07380737
Tel-Aviv Sourasky Medical CenterN/A
RecruitingTemporal Interference Stimulation on Motor Symptoms in Parkinson's Disease
NCT07309198
Shanghai University of SportN/A
Not Yet RecruitingMenthol for Improving Movement and Sleep in Parkinson's Disease Patients
NCT07294469
Taipei Medical University HospitalPhase 2
Not Yet RecruitingAn Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen
NCT07279844
Anhui Provincial Hospital
RecruitingOpen-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease
NCT07348250
InvicroEARLY_Phase 1
Not Yet RecruitingExpiratory Muscle Training in Parkinson's Disease With Forward Trunk Flexion
NCT07268703
General University Hospital, PragueN/A
RecruitingMRgFUS for Parkinson's Tremor
NCT07284719
Aarhus University HospitalN/A
Not Yet RecruitingPrevent Cognitive Decline in GBA-associated Parkinson's Disease
NCT07055087
University Hospital TuebingenPhase 2
RecruitingA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage
NCT07174310
Hoffmann-La RochePhase 3
RecruitingAdaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
NCT07216976
MedtronicNeuroN/A
RecruitingColonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behav
NCT07217054
CND Life Sciences
Enrolling By InvitationTurkish Validation of the Parkinson Disease Cognitive Functional Rating Scale
NCT07253376
Gazi University
Enrolling By InvitationAB-1005 Long-Term Follow-up Study
NCT07081841
AskBio Inc
RecruitingThe Safety and Tolerability of XS411CN Injection in Treatment of Primary Parkinson's Disease
NCT07080775
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.Phase 1
RecruitingA Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tiss
NCT06683378
Craig van Horne, MD, PhDPhase 1
RecruitingEpidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease
NCT06920134
Ecole Polytechnique Fédérale de LausanneN/A
RecruitingEvaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
NCT07020026
Michael J. Fox Foundation for Parkinson's ResearchPhase 2
RecruitingStudy to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial St
NCT06916507
AbbVie
RecruitingWhich Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported,
NCT07148700
Bezmialem Vakif University
RecruitingStudy on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
NCT06937034
AbbVie
RecruitingCombined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
NCT05968703
Helen M. Bronte-StewartN/A
Not Yet RecruitingCognitive Cueing and Video Intervention for Gait in Parkinson's Disease
NCT06894030
Western University, CanadaN/A
Not Yet RecruitingA Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Diseas
NCT06175767
Mthera Pharma Co., Ltd.Phase 2
Enrolling By InvitationDual-Task Balance and Gait Training Combined With Cognitive Training in Parkinson's Patients
NCT07213232
Gazi UniversityN/A
RecruitingTenapanor in Synucleinopathy-Related Constipation
NCT06460038
Cedar Valley Digestive Health CenterPhase 2
RecruitingDevelopment of Digital Services for Parkinson's Disease
NCT06733077
University of ExeterN/A
RecruitingA Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Pa
NCT06753331
Sumitomo Pharma America, Inc.Phase 1 / Phase 2
Not Yet RecruitingCombined Genome and RNA Sequencing for Genetic Diagnosis of Parkinsonism
NCT06576713
University Hospital, Strasbourg, FranceN/A
RecruitingA Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
NCT06596876
Jiangsu HengRui Medicine Co., Ltd.Phase 3
RecruitingKinematic and Neural Dynamics of Postural Instability in Parkinson's Disease
NCT06405334
VA Office of Research and Development
RecruitingEfficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care P
NCT06581523
Nova Southeastern UniversityN/A
RecruitingStudy of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients
NCT06713265
Hopital La Musse
WithdrawnDetection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Prot
NCT04536857
Huashan Hospital
Not Yet RecruitingCilostazol in Parkinson's Disease
NCT06612593
Ain Shams UniversityPhase 2
Active Not RecruitingA Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease
NCT06480461
Shanghai Vitalgen BioPharma Co., Ltd.Phase 1 / Phase 2
RecruitingFeasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
NCT06028529
VA Office of Research and DevelopmentN/A
Enrolling By InvitationThe Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) Targeting the Right Globus Pa
NCT06931483
Yanghua TianN/A
RecruitingImaging Depression in Parkinson's Disease
NCT06402955
Yale UniversityPhase 2
RecruitingA Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
NCT06565195
Prevail TherapeuticsPhase 1
Not Yet RecruitingEffect of Virtual Reality on Freezing Phenomenon, Balance, Functional Mobility, Participation in Parkinson's P
NCT06390553
Ankara Yildirim Beyazıt UniversityN/A
Enrolling By InvitationA Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmaco
NCT06537050
Zhejiang Jingxin Pharmaceutical Co., Ltd.Phase 1
Not Yet RecruitingKeep On Keep Up for Parkinson's
NCT06332794
Northumbria UniversityN/A
CompletedDASH Diet, Triglycerides and AIP in Parkinson's Disease
NCT07402993
Abant Izzet Baysal University
CompletedDual-task Augmented Reality for PD DBS
NCT06418152
Jay AlbertsN/A
RecruitingPET Imaging Evaluation of [11C]SY08
NCT06098612
Massachusetts General HospitalEARLY_Phase 1
RecruitingExercise as Treatment of Fatigue in Parkinson´s Disease
NCT06324422
University of AarhusN/A
UnknownImpulse Control Disorder Among Parkinson's Disease Patients
NCT06289855
Assiut University
RecruitingResearch on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Ran
NCT06232772
Yousheng Xiao
RecruitingA Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis
NCT06304285
The First Affiliated Hospital of University of Science and Technology of ChinaN/A
RecruitingAction Observation and Motor Imagery Therapy in Parkinson's Disease
NCT06154356
Karamanoğlu Mehmetbey UniversityN/A
CompletedTurning Pattern of Different Body Segments During Turns and Turning Performance
NCT05929781
National Yang Ming Chiao Tung University
RecruitingA Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells
NCT06145711
Shanghai East HospitalN/A
Enrolling By InvitationLong Term Follow Up KET-PD
NCT06164756
Yale University
CompletedRepurposing Lithium for Parkinson's Disease
NCT06099886
State University of New York at BuffaloPhase 1
UnknownEffects of STN DBS on Cognition and Brain Networks in PD Patients Analyzed Based on EEG and fNIRS
NCT06175897
Zhiqi MaoN/A
CompletedStudy to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's
NCT06036368
Stimvia s.r.o.N/A
Active Not RecruitingLong Term Follow-up of Patients With Parkinson's Disease Who Had Administered of A9-DPC in SB-PD-001 Study
NCT06477744
S.Biomedics Co., Ltd.N/A
CompletedEarly Parkinson's Disease Monotherapy With CVN424
NCT06006247
Cerevance Beta, Inc.Phase 2
RecruitingRepetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson'
NCT06002581
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineN/A
Active Not RecruitingThe Effects on Physical Activity on Mitochondrial Function in Skin Fibroblasts in Patients with Parkinson's Di
NCT05963425
University Ramon LlullN/A
CompletedThe HIIT-Home4Parkinson's Study
NCT05485428
University of PlymouthN/A
RecruitingOcular Microtremor in Parkinson's Disease.
NCT06051877
Northumbria University
RecruitingSafety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease
NCT05997043
Zhujiang HospitalEARLY_Phase 1
Not Yet RecruitingiPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS
NCT05810454
iPACES LLCN/A
RecruitingStudy on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Dig
NCT07392411
Beijing Tiantan Hospital
UnknownA Multicenter Clinical Study of rTMS for Parkinson's Disease
NCT06009471
Affiliated Hospital of Nantong UniversityN/A
CompletedPsychological Ressources, Anxiodepressive Symptoms, Well-being and Therapeutical Observance in Parkinson's Dis
NCT05919628
Central Hospital, Nancy, France
RecruitingSafety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
NCT05901818
Xuanwu Hospital, BeijingPhase 1
UnknownProgramming Strategy of VFS for Gait Impairments in PD
NCT05905198
Peking Union Medical College HospitalN/A
Active Not RecruitingLong-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease
NCT05894343
MeiraGTx, LLCPhase 1 / Phase 2
CompletedPharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fl
NCT06614153
Jiangsu HengRui Medicine Co., Ltd.Phase 2
CompletedStudy to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients
NCT05887466
S.Biomedics Co., Ltd.Phase 1 / Phase 2
RecruitingItalian Translation and Validation of the Non-Motor Fluctuation Assessment (NoMoFA) Questionnaire: an Observat
NCT06406374
A.O.U. Città della Salute e della Scienza
Active Not RecruitingThe Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's Disease
NCT05779137
Radboud University Medical CenterN/A
CompletedSafety and Efficacy Study of Parkinson's Disease Gene Therapy Drug (BBM-P002)
NCT05822739
Xiangya Hospital of Central South UniversityEARLY_Phase 1
Active Not RecruitingEfficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
NCT05819359
Bial R&D Investments, S.A.Phase 2
RecruitingPatterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's D
NCT05830110
Synergic Medical Technologies, Inc.N/A
RecruitingNMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian
NCT06490926
Fujian Medical University Union Hospital
WithdrawnGondola Mechanism of Action
NCT05146648
Icahn School of Medicine at Mount SinaiN/A
Active Not RecruitingTelemedicine Intervention in Patients With Chronic Pain in PD
NCT05410392
VA Office of Research and DevelopmentN/A
UnknownPrecise Transplantation of hAESCs Into the Ventricle for Parkinson's Disease.
NCT05435755
Shanghai East HospitalEARLY_Phase 1
TerminatedMixed Music Intervention on Sleep Disturbance in Patients With Parkinson's Disease
NCT05489653
Taipei Medical UniversityN/A
CompletedCombining Aerobic Exercise and Virtual Reality for Cognitive-motor Rehabilitation in PD
NCT05385497
The University of Texas Health Science Center at San AntonioN/A
UnknownThe Effectiveness of Motor-motor and Motor-cognitive Dual-task Training Interventions on Balance in People Wit
NCT05710588
University of PlymouthN/A
RecruitingNatural History Protocol for Movement Disorders
NCT05413291
National Institute of Neurological Disorders and Stroke (NINDS)
RecruitingParkinson's Disease in Asian Americans
NCT05532982
Tufts University
CompletedRelative Bioavailability and Food Effect Study of CVN424
NCT05635461
Cerevance Beta, Inc.Phase 1
CompletedA Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Partic
NCT05603312
MeiraGTx, LLCPhase 1 / Phase 2
RecruitingDeep Brain Stimulation for Visuomotor Function in Parkinson's Disease
NCT05400499
VA Office of Research and Development
CompletedRepetitive Transcranial Magnetic Stimulation for Musculoskeletal Pain in Patients With Parkinson's Disease
NCT05537597
Second Affiliated Hospital of Soochow UniversityN/A
RecruitingHome-based Transcranial Static Magnetic Field Stimulation (tSMS) of the Supplementary Motor Area in Parkinson'
NCT06840678
Fundación de investigación HMPhase 1
Active Not RecruitingPre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
NCT05699460
AskBio Inc
CompletedPerception in Parkinson's Disease
NCT05483036
Boston University Charles River Campus
RecruitingTelerehabilitation in People With Parkinson's Disease
NCT05773885
IRCCS San Raffaele RomaN/A
TerminatedAn Extension Study to Evaluate the Long-Term Efficacy, Safety and Tolerability of Minzasolmin (UCB0599) in Stu
NCT05543252
UCB Biopharma SRLPhase 2
CompletedA Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension
NCT05523570
Guangzhou Henovcom Bioscience Co. Ltd.Phase 1
Active Not RecruitingNoninterventional Study Evaluating Parkinson's Disease Diary Use
NCT05363046
BlueRock Therapeutics
CompletedA Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers
NCT05844787
Mthera Pharma Co., Ltd.Phase 1
Active Not RecruitingFeasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (G
NCT05377281
Craig van Horne, MD, PhDPhase 1
RecruitingSerotonin Release in Premotor and Motor PD
NCT05516732
University of Exeter
RecruitingEffect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
NCT05576818
Tanta UniversityPhase 3
WithdrawnTransplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease
NCT03309514
NeuroGenerationPhase 1 / Phase 2
CompletedBiomarkers of Neurodegeneration and Neuroplasticity in Parkinson's Disease Patients Treated by Bilateral M1-iT
NCT06840145
Instituto de investigación e innovación biomédica de CádizN/A
CompletedA Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's D
NCT05435729
Sumitomo Pharma Co., Ltd.Phase 1
RecruitingExploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalami
NCT04735172
University Hospital, Clermont-FerrandN/A
RecruitingRemote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
NCT05298150
VA Office of Research and DevelopmentN/A
CompletedDevelopment and Validation of a Scale Measuring Preoperative Expectations in Parkinson's Disease
NCT04933513
Central Hospital, Nancy, France
UnknownInterleaving Stimulation Improves Dyskinesia in Parkinson's Disease
NCT06239454
Huashan HospitalN/A
Not Yet RecruitingSystematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pum
NCT05072015
University Hospital, Strasbourg, France
CompletedStudy to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participan
NCT05094050
AbbViePhase 1
UnknownMAPT Haploid H1b and the Damage of BBB in Dorsal Medulla Oblongata and Autonomic Dysfunction in PD
NCT05471713
Zhujiang Hospital
WithdrawnAttentional Performance in Parkinson Disease
NCT04428931
National Institute of Neurological Disorders and Stroke (NINDS)
CompletedKetamine for the Treatment of Depression in Parkinson's Disease
NCT04944017
Yale UniversityPhase 2
CompletedAn Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)
NCT05638815
SciNeuro
UnknownEffects of Probiotics on Peripheral Immunity in Parkinson's Disease
NCT05173701
Franca MarinoN/A
RecruitingAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
NCT05070013
University of NebraskaN/A
RecruitingLongitudinal Investigation of I2BS in PD
NCT05516719
University of Exeter
RecruitingThe Swedish BioFINDER Sleep Study
NCT07533799
Skane University Hospital
CompletedRelative Bioavailability Study of HRG2010 in Healthy Subjects
NCT06976346
Jiangsu HengRui Medicine Co., Ltd.Phase 1
RecruitingPET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873
National Institute of Mental Health (NIMH)Phase 1
CompletedEffectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease
NCT05992701
Beijing Pins Medical Co., LtdN/A
CompletedAn RCT of a Telemedicine Intervention for Hypokinetic Dysarthria in PD
NCT04617496
VA Office of Research and DevelopmentN/A
UnknownThe Practical Effect of Neupro
NCT04957420
Peking University Third Hospital
UnknownPredictive Value of Multimodal MRI in Parkinson's Disease
NCT05003206
Chinese PLA General HospitalN/A
CompletedAssessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse
NCT04778176
SynAgile CorporationPhase 2
CompletedInnovative Treatments for Neurogenic Dysphagia
NCT07152899
IRCCS National Neurological Institute "C. Mondino" FoundationN/A
TerminatedParkinson's Disease G2019S LRRK2 Genetic Testing Program
NCT04919356
Escape Bio, Inc.
CompletedVestibulopathy as a Cause of Imbalance in Parkinson
NCT04768647
VA Office of Research and DevelopmentPhase 1 / Phase 2
TerminatedImaging a Cholinergic Biomarker of Cognition in Parkinson's Disease
NCT05034263
Stony Brook University
RecruitingNovel DBS Stimulation Patterns for Treatment of Parkinson's Disease
NCT04799470
University of NebraskaN/A
UnknownEfficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease With Constipat
NCT04837313
Guangzhou First People's HospitalN/A
CompletedA Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants
NCT04867642
UCB Biopharma SRLPhase 1
CompletedStudy to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Partici
NCT04500106
AbbVie
Active Not RecruitingObjective Assessment of Behavioural Disorders in PD
NCT04611581
Insel Gruppe AG, University Hospital Bern
UnknownShort Pulse Width Versus Low Frequency DBS in Parkinson's Disease
NCT05034510
University Hospital of FerraraN/A
Unknownto Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteer
NCT04593511
Luye Pharma Group Ltd.Phase 1
Active Not RecruitingPartnered Dance Aerobic Exercise as a Neuroprotective, Motor and Cognitive Intervention in Parkinson's Disease
NCT04122690
VA Office of Research and DevelopmentN/A
CompletedAcute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and
NCT04584346
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1
CompletedStudy to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain
NCT06445465
InvicroEARLY_Phase 1
RecruitingParkinson's Foundation PD GENEration Genetic Registry
NCT04994015
Parkinson's Foundation
TerminatedSingle-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barri
NCT04652843
Nantes University HospitalN/A
CompletedA Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parki
NCT04651153
UCB Biopharma SRLPhase 1
RecruitingInternational Validation of Two Non-motor Scales in PD (NFS and SPARK)
NCT04366804
Insel Gruppe AG, University Hospital Bern
CompletedPhase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiop
NCT04506073
The University of Texas Health Science Center, HoustonPhase 2
CompletedClinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's D
NCT04565080
National Institute of Neurological Disorders and Stroke (NINDS)
UnknownSimpler and Safer Deep Brain Stimulation for Parkinson's Disease
NCT03837314
North Bristol NHS TrustN/A
UnknownCognitive-motor Training for PD
NCT01917903
Stony Brook UniversityN/A
UnknownResearch on the Effect and Mechanism of Aerobic Exercise on PD
NCT04651140
The First Hospital of Jilin UniversityN/A
CompletedStereotactic Transplantation of hAESCs for Parkinson's Disease
NCT04414813
Shanghai East HospitalEARLY_Phase 1
CompletedMapping the Target for the MRgFUS Treatment of Tremor
NCT04661241
NYU Langone HealthN/A
RecruitingSensory-specific Peripheral Stimulation for Tremor Management
NCT04501133
Shirley Ryan AbilityLabN/A
UnknownInteractive Stepping Exercise on Balance and Cognitive Function
NCT04494906
National Yang Ming Chiao Tung UniversityN/A
CompletedRemote Ischemic Conditioning for Parkinson's Disease
NCT04327687
General Hospital of Shenyang Military RegionN/A
CompletedMultiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
NCT04449484
AstraZenecaPhase 1
TerminatedStudy on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets
NCT04275492
First Affiliated Hospital of Zhejiang UniversityN/A
RecruitingEvaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
NCT04179695
University Hospital, LilleN/A
UnknownStudy on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease
NCT04926909
Second Affiliated Hospital, School of Medicine, Zhejiang University
CompletedPoised for Parkinson's - an Intervention to Increase Embodied Agency in People With Parkinson's Disease and Th
NCT04726709
University of IdahoN/A
Active Not RecruitingEffects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease
NCT06365190
Anhui Medical UniversityN/A
RecruitingrTMS to Improve Cognition in Parkinson's
NCT03836950
VA Office of Research and DevelopmentPhase 1 / Phase 2
Active Not RecruitingGDNF Gene Therapy for Parkinson's Disease
NCT04167540
Brain Neurotherapy Bio, Inc.Phase 1
CompletedA Through QT/QTc Study of KW-6356
NCT04342273
Kyowa Kirin Co., Ltd.Phase 1
WithdrawnA Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease
NCT04127695
AbbViePhase 1
WithdrawnInduction and Recognition of Emotions
NCT04353947
University of Valencia
Active Not RecruitingGenotypic Influences on Network Progression in Parkinson's Disease
NCT04228172
Northwell Health
CompletedCognitive Rehab for Parkinson's
NCT03836963
VA Office of Research and DevelopmentN/A
UnknownExenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
NCT04232969
University College, LondonPhase 3
CompletedMindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study
NCT03998462
VA Office of Research and DevelopmentN/A
TerminatedLow Dose Niacin (Vitamin B3) for Parkinson's Disease
NCT03808961
VA Office of Research and DevelopmentN/A
Completed31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease
NCT03815916
Clene NanomedicinePhase 2
CompletedAn Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD
NCT03994328
Zambon SpA
WithdrawnA Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease
NCT03436953
Jazz PharmaceuticalsPhase 2
UnknownUsing DBS to Probe Basal Ganglia Dysfunction
NCT04080674
University of Oxford
CompletedGait Characteristics and Cognitive Evolution in Parkinson Disease
NCT04297800
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
TerminatedStudy to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Sympt
NCT04164758
ACADIA Pharmaceuticals Inc.Phase 2
CompletedStaccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease
NCT04157933
Alexza Pharmaceuticals, Inc.Phase 1
CompletedSafety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects
NCT04165837
1ST Biotherapeutics, Inc.Phase 1
WithdrawnCircadian & Homeostatic Synchronization Effect on Waking Mobility in Parkinson's Disease
NCT04467632
University Hospital Center of MartiniqueN/A
CompletedHighly Challenging Balance Program to Reduce Fall Rate in PD
NCT03972969
VA Office of Research and DevelopmentN/A
Active Not RecruitingEfficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in
NCT04006210
NeuroDerm Ltd.Phase 3
CompletedDifferences Between Patients With Vascular Parkinsonism and Parkinson's Disease
NCT04308135
Ain Shams University
UnknownIntensity of Aerobic Training and Neuroprotection in Parkinson's Disease
NCT04046276
Assistance Publique - Hôpitaux de ParisN/A
CompletedStudy of UB-312 in Healthy Participants and Parkinson's Disease Patients
NCT04075318
United Neuroscience Ltd.Phase 1
CompletedA Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin
NCT04070495
Kyowa Kirin Co., Ltd.Phase 1
CompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disea
NCT03976349
Ionis Pharmaceuticals, Inc.Phase 1
UnknownSingle Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subj
NCT04043338
Xoc PharmaceuticalsPhase 1
Active Not RecruitingCan Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disea
NCT04578678
Insel Gruppe AG, University Hospital Bern
UnknownConcurrent Transcranial Direct Current Stimulation and Gait Training in Parkinson's Disease
NCT04041661
National Yang Ming Chiao Tung UniversityN/A
CompletedTelehealth Psychotherapy for Depression in Parkinson's Disease
NCT03993041
Boston University Charles River CampusN/A
UnknownPhase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's
NCT06021756
University of ArizonaPhase 1
CompletedStudy to Evaluate DNL151 in Subjects With Parkinson's Disease
NCT04056689
BiogenPhase 1
UnknownNocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai
NCT04023201
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
CompletedAerobic Exercise in Parkinson's Disease
NCT03808675
VA Office of Research and DevelopmentN/A
RecruitingThe Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
NCT03945968
Russian Federation of Anesthesiologists and Reanimatologists
CompletedEvaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool
NCT03794661
Abbott Medical DevicesN/A
UnknownPredicting Cognition After DBS for Parkinson's Disease
NCT03982953
Charite University, Berlin, Germany
CompletedCognitive Control in Parkinson's Disease
NCT03981913
Rennes University Hospital
CompletedRostock International Parkinson's Disease Study (ROPAD)
NCT03866603
CENTOGENE GmbH Rostock
CompletedA Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin
NCT03970798
Kyowa Kirin Co., Ltd.Phase 1
CompletedStudy of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease:
NCT03552068
Hospices Civils de LyonPhase 2
CompletedA Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Pa
NCT04875962
UCB Biopharma S.P.R.L.Phase 1
TerminatedInnovative Biomarkers in de Novo Parkinson's Disease
NCT03940677
University Hospital, GrenobleN/A
TerminatedA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Partic
NCT03716570
BiogenPhase 1
CompletedPharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)
NCT03887884
Acorda TherapeuticsPhase 1
CompletedA Study of Single and Multiple Doses of KW-6356 in Healthy Subjects
NCT03830528
Kyowa Kirin Co., Ltd.Phase 1
CompletedMulti-chip Meta-analysis of Parkinson's Disease for Clinical Validation of Small Samples of Key Genes in Disea
NCT03848455
Zhujiang Hospital
CompletedOvercoming Gait Freeze in Parkinson's Disease Using Responsive Cueing
NCT05019469
University of OxfordN/A
UnknownThe Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PD
NCT03227783
Inje UniversityN/A
CompletedTrial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study
NCT03840005
Sheffield Teaching Hospitals NHS Foundation TrustPhase 2
CompletedThe Effects of a High Intensity Exercise Training Program in Patients With Parkinson's Disease
NCT02593955
University of Alabama at BirminghamN/A
CompletedTraining With Exergame and Treadmill on Executive Function and Dual-task Performance
NCT03623841
National Yang Ming Chiao Tung UniversityN/A
CompletedRasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"
NCT03727139
Takeda
CompletedVY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)
NCT03562494
Neurocrine BiosciencesPhase 1
CompletedA Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
NCT03703570
Kyowa Kirin Co., Ltd.Phase 2
Active Not RecruitingClinical Laboratory Evaluation of Chronic Autonomic Failure
NCT03648905
National Institute of Neurological Disorders and Stroke (NINDS)
RecruitingDistinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
NCT03019757
Douglas Scharre
CompletedObservational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies
NCT03733496
Neurocrine Biosciences
CompletedEfficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease
NCT04455555
Peking University Third HospitalPhase 3
UnknownExploit the Neural Source and the Feasibility of Transcranial Direct Current Stimulation for Freezing of Gait
NCT03721887
China Medical University HospitalN/A
CompletedUse and Misuse of Domperidone in Parkinson's Disease in France - Dump Investigation
NCT03837067
Assistance Publique - Hôpitaux de Paris
CompletedEffects of Exenatide on Motor Function and the Brain
NCT03456687
University of FloridaPhase 1
CompletedThe Study of Acupuncture on Vascular and Functional Neuroimaging in Parkinson's Disease Patients With Sleep Di
NCT03501004
Tsinghua UniversityN/A
CompletedFeasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease
NCT03696589
Teachers College, Columbia UniversityPhase 1 / Phase 2
CompletedTherapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal
NCT03541356
Impel PharmaceuticalsPhase 2
CompletedShort Pulse Width DBS in Parkinson's Disease
NCT03417271
University College, LondonPhase 2
UnknownCombined Stimulation of STN and SNr for Dysphagia in Parkinson's Disease
NCT03470324
University Hospital TuebingenN/A
CompletedEffects of RAC With Locomotion Training on Cortical Excitability and Behavior in Patients With PD
NCT03656796
National Taiwan University HospitalN/A
CompletedA Standardized Meditation Technique "Body-scan", in the Management of Anxiety in Hospitalized Parkinsonian Pat
NCT03349554
University Hospital, BordeauxN/A
UnknownRole of Retina in Mechanisms of Illusions and Visual Hallucinations Observed in Idiopathic Parkinson's Disease
NCT03454269
University Hospital, Clermont-FerrandN/A
TerminatedEfficacy of a Recreation Therapy Wellness Recovery Program for Individuals With Parkinson's Disease
NCT04164043
Wake Forest University Health SciencesN/A
CompletedImpact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Diseas
NCT02925065
Johns Hopkins UniversityN/A
UnknownEffect of High Intensity Interval Training on Mechanisms of Neuroplasticity in Parkinson's Disease Patients
NCT04204551
Wroclaw University of Health and Sport SciencesN/A
CompletedSafety and Efficacy of DA-9805 for Parkinson's Disease
NCT03189563
Dong-A ST Co., Ltd.Phase 2
UnknownMulti-disciplinary Rehabilitation Program for Advanced Parkinson's Patients in the Community
NCT03406754
Tel-Aviv Sourasky Medical Center
CompletedGenetic Influences on Response to Gait Rehabilitation in Parkinson's Disease
NCT03607695
VA Office of Research and DevelopmentN/A
CompletedFalls and Balance of Patients With Parkinson's Disease With Urinary Disturbance
NCT03845725
Ordu University
WithdrawnGait Disorders in Parkinson's Disease
NCT03416452
National Institute of Neurological Disorders and Stroke (NINDS)EARLY_Phase 1
CompletedAttributional Style and Parkinson's Disease
NCT03371277
CHU de ReimsN/A
UnknownUmbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease
NCT03550183
Hebei Newtherapy BIo-Pharma technology Co., Ltd.Phase 1
TerminatedEvaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkin
NCT03318523
BiogenPhase 2
CompletedAllogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease
NCT02611167
The University of Texas Health Science Center, HoustonPhase 1
CompletedMeasuring Parkinson's Disease Progression
NCT03205956
Kevin J. Black, MDPhase 1
CompletedSingle Ascending Dose Study of MEDI1341 in Healthy Volunteers
NCT03272165
AstraZenecaPhase 1
TerminatedDNS-7801 vs. Placebo in Parkinson's Disease
NCT03306329
Dart NeuroScience, LLCPhase 2
CompletedA Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's D
NCT03187301
Sumitomo Pharma America, Inc.Phase 2
UnknownDetermining Clinical Profile of Parkinson's Disease Among Egyptian Population
NCT02785510
Zagazig University
CompletedState-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With Deep Brain Stimulati
NCT02709148
University of MinnesotaPhase 1
RecruitingRetinal Imaging in Neurodegenerative Disease
NCT03233646
Duke University
WithdrawnCharacterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patien
NCT03026231
The University of Texas Health Science Center, HoustonPhase 1 / Phase 2
CompletedCrossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Projec
NCT04403399
University of MichiganPhase 2
Active Not RecruitingA Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Dis
NCT03100149
Hoffmann-La RochePhase 2
CompletedEffect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
NCT03111485
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 4
CompletedSafety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
NCT03065192
Neurocrine BiosciencesPhase 1
CompletedEvaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
NCT03047629
Enterin Inc.Phase 1 / Phase 2
UnknownApomorphine in Parkinson's Disease Patients With Visual Hallucinations
NCT02702076
University Medical Center GroningenPhase 2
UnknownSafety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease
NCT03119636
Chinese Academy of SciencesPhase 1 / Phase 2
CompletedStudy to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´
NCT03103919
UCB Biopharma S.P.R.L.Phase 4
UnknownApomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
NCT02864004
Rennes University HospitalPhase 3
CompletedTelephone-linked Home-based Exercise Training in PD
NCT02898740
VA Office of Research and DevelopmentN/A
UnknownEvolution of RBD in PD
NCT03047408
University Hospital, Clermont-FerrandN/A
UnknownThe Effects of Multi-focal tDCS on Motor-cognitive Dysfunctions in Parkinson's Disease
NCT02656316
Tel-Aviv Sourasky Medical CenterN/A
CompletedCortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients
NCT03131817
Simon J. Little, MBBS, PhDN/A
TerminatedA Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's D
NCT02906020
Genzyme, a Sanofi CompanyPhase 2
CompletedImage Parkinson's Disease Progression Study
NCT02789020
University of FloridaPhase 2
Active Not RecruitingGlobal Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:
NCT03100474
InSightec
CompletedrTMS for the Treatment of Freezing of Gait in Parkinson's Disease
NCT03219892
Xuanwu Hospital, BeijingN/A
UnknownEvaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease
NCT02929628
Beijing Pins Medical Co., LtdPhase 2
Active Not RecruitingBright Light Therapy for Non-motor Symptoms in Parkinson's Disease
NCT02909192
Massachusetts General HospitalN/A
WithdrawnA Multidisciplinary Approach to Manage Gait Difficulty in Parkinson Patients
NCT02857244
University of ChicagoPhase 2
WithdrawnPiloting a Novel, Mobile Cognitive Tracking and Training Tool for Patients With Parkinson's Disease (PD)
NCT02922530
Posit Science CorporationN/A
CompletedPhase I, KM-819 in Healthy Subjects for Parkinson's Disease
NCT03022799
Kainos Medicine Inc.Phase 1
CompletedEffect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease
NCT03243214
University of CalgaryN/A
CompletedStudy of Parkinson's Early Stage With Deferiprone
NCT02728843
ApoPharmaPhase 2
CompletedDBS of the MLR for Gait and Balance Disorders in PD Patients
NCT02931097
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
TerminatedUsing [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease Patient
NCT02538315
University of Saskatchewan

Showing the 300 most recent trials. Use search for older records.